Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Exceptional Strength! Healthy Yuan Selected for the Top 9 of the "2019 Top 100 Chinese Chemical Pharmaceutical Enterprises Ranking"
Published Time：
2020-07-23
The highly anticipated 2019 Top 100 Chinese Pharmaceutical Industry Rankings were recently released!
Jiankangyuan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jiankangyuan"), with its solid R&D and production capabilities and stable market promotion capabilities, successfully entered the "2019 Top 100 Chinese Pharmaceutical Industry Rankings" sub-list "2019 Top 100 Chinese Chemical Pharmaceutical Enterprises" ranking Top 9!
It is understood that this series of rankings was organized by the Mi Nei Research Institute's China Pharmaceutical Industry Top 100 Ranking Expert Committee, relying on the Mi Nei Network's unique, long-running database of three major terminals and six major market terminal structures in China. The rankings evaluate pharmaceutical companies based on two key dimensions: innovation driving force and professional promotion capabilities.
The "2019 Top 100 Chinese Pharmaceutical Industry Rankings" consists of 5 sub-rankings:
"Top 100 Chinese Chemical Pharmaceutical Enterprises", "Top 100 Chinese Traditional Chinese Medicine Enterprises", "Top 20 Chinese CRO (including CDMO) Enterprises", "Top 20 Chinese Medical Devices (including IVD) Enterprises", and "Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Enterprises", totaling 260 companies on the list.
The total score of the selected companies consists of two parts: firstly, the company's innovation driving force, i.e., the 2019 R&D investment comprehensive index score, accounting for 40% of the weight; secondly, the company's professional promotion capabilities, i.e., the score determined by the quantitative data of the final choices of clinical doctors and patients in 2019, which is defined by combining the Mi Nei Network's unique data from three major terminals and six major market terminals for quantitative analysis, accounting for 60% of the weight.
Jiankangyuan, as a comprehensive group company integrating the R&D, production, sales, and service of pharmaceuticals and health foods, has been adhering to its unique and innovative R&D technology platforms, such as the respiratory drug delivery technology platform, in recent years to seize the development opportunities in the respiratory drug market. It has continuously expanded its presence in the respiratory field. After years of development, the company has now formed a relatively focused and clear product R&D pipeline, and its inhalation preparation business is gradually entering the harvest period. After the epidemic, with the rapid deepening and transformation of many industrial policies, the pharmaceutical and health industry needs to return to its essence, its industrial value, and its health goals. Jiankangyuan, which has been deeply involved in the great health field for many years, remains committed to its original aspirations. Its inclusion in this ranking is a recognition by the market of the company's hard work and its exemplary role for society and the industry in recent years.
According to the organizer, the final rankings of the "2019 Top 100 Chinese Pharmaceutical Industry Rankings" will be grandly awarded at the "2020 National Pharmacy Week and China Pharmaceutical Industry Top 100 Annual Meeting, China Pharmaceutical Internet Economy Annual Meeting" to be held in Yunnan from August 25th to 28th, 2020. Let's wait and see!
Source: Investment Community
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.